Ryan Hagle Email & Phone Number | Associate scientist in CAR-T process development at AstraZeneca. I currently work to optimize the process used for CAR-T production in order to improve clinical performance for patients. I find it rewarding to be able to think critically and test new hypotheses to improve our process on products that are close to clinical stages. My previous research focused on identifying genes and regulatory elements that control fin and heart regeneration in a zebrafish model. I worked to develop a stable knock-in fluorescence reporter line using CRISPR-Cas9 for targeted gene integration. In the Kang lab, I contributed to two publications, one as a co-author, and one as a first author.

Ryan Hagle

Associate scientist in CAR-T process development at AstraZeneca. I currently work to optimize the pr...
Gaithersburg, Maryland, United States

*50 free lookup(s) per month.

Ryan Hagle’s Phone Numbers

Get RYAN’s Phone Number (For Free)

Social Media

Ryan Hagle’s Location Gaithersburg, Maryland, United States

Ryan Hagle’s Current Industry Astrazeneca

Ryan Hagle’s Prior Industry University Of Wisconsin Madison | Abbvie

Find accurate emails & phone numbers for over 700M professionals.

Associate Scientist, Cell Therapy

2023-05-01 00:00:00 - Present

Research Intern

2022-12-01 00:00:00 - 2023-05-01 00:00:00

Transformational And Translational Immunology Discovery Intern

2022-05-01 00:00:00 - 2022-08-01 00:00:00

No Skills Available

No Languages Available

Ryan Hagle is a Associate scientist in CAR-T process development at AstraZeneca. I currently work to optimize the process used for CAR-T production in order to improve clinical performance for patients. I find it rewarding to be able to think critically and test new hypotheses to improve our process on products that are close to clinical stages. My previous research focused on identifying genes and regulatory elements that control fin and heart regeneration in a zebrafish model. I worked to develop a stable knock-in fluorescence reporter line using CRISPR-Cas9 for targeted gene integration. In the Kang lab, I contributed to two publications, one as a co-author, and one as a first author.